PubMed Health⌕ Search

Biomedical subjects

Arne V Astrup

Publications and source records attributed to Arne V Astrup.

At least 19 recordsLinked to original sources
PubMed2006

[High levels of industrially produced trans fatty acids in popular fast food - but not in Denmark--secondary publication].

An intake of trans-fatty acids of 5 grams per day is associated with an increase of 25% in the risk of ischemic heart disease. In 2004 Denmark, as the first country in the world, introduced a limitation on the content of industrially produced trans-fatty acids in foods. The amount in a "high-trans menu" consisting of popular foods was, from 2001 to 2005, reduced in Denmark from 30 g to <1 g. The amount in the same menu bought in countries within and outside the European Union is 20-40 g. During a period of just a few years, Denmark has thus eliminated a risk factor for ischemic heart disease without noticeable side effects for consumers. This risk factor is, however, still present in many other countries.

Animals↗
PubMed2006

[Obesity in Denmark--why has it not gone so badly?].

In the Western world the number of obese people is increasing, but in Denmark the incidence is not on the same scale as in the USA. Although several factors may be of importance, Danes are more physically active and their intake of beverages with added sugar is less than in the American population.

Denmark↗
PubMed2006

[Alternative causes of obesity].

The prevailing understanding of the causes of obesity is based on the disturbance of the thermodynamic law of energy balance, primarily through increased intake or decreased expenditure of energy. Alternative causes of obesity, which still respect the law but also allow for primary fat accumulation, are: virus infection of fat cells, energy supply from bacterial fermentation of indigestible food components, psychosocial factors mediated by psychoneuroendocrine pathways, sleeplessness or poor quality of sleep and early life programming, in addition to the well-known and proven genetic programming.

Animals↗
PubMed2006

[The importance of physical activity and fitness in avoiding the complications of obesity].

We have reviewed whether the complications of obesity can be attributed to low levels of physical activity and fitness, or if fatness per se has adverse effects on health. In both observational and interventional studies, fatness and inactivity seem to be independent risk factors. Abdominal obesity is a predictor of cardiovascular disease, which is independent of low fitness level, and obesity affects other risk factors adversely than inactivity does. However, physical activity does reduce the risk of type 2 diabetes and heart disease. It is concluded that both inactivity and obesity have an adverse effect on health.

Body Mass Index↗
PubMed2006

[Drug treatment of obesity].

Acceptable adverse effects and a clinical relevant weight loss of 3 to 5 kilograms have been found in long-term randomized clinical trials for sibutramine (Reductil) and orlistat (Xenical); these drugs may be prescribed for treatment of obesity for a duration of one and four years, respectively. This also seems to be the case for rimonabant (Acomplia), which is expected to receive approval in 2005 or 2006. However, until data on morbidity and mortality are available from RCTs, there is no absolute indication for prescribing drugs for treatment of obesity.

Anti-Obesity Agents↗